China Medical University, China

This study tests a combination of two drugs, sacituzumab tirumotecan and anlotinib, in people with extensive-stage small cell lung cancer whose disease has worsened after initial treatment with immunotherapy and chemotherapy. The goal is to see if this new combination can shrink …

This study tests whether a combination of drugs (irinotecan liposome, platinum, an immune checkpoint inhibitor, and anlotinib) can help keep extensive small cell lung cancer from growing after initial treatment. About 31 adults with this aggressive lung cancer will receive the dr…

This early-stage study tests a new treatment for people with colorectal cancer that has spread to the liver and hasn't responded to standard therapies. The treatment combines a modified virus (BioTTT001) that targets cancer cells, with two drugs (toripalimab and regorafenib) that…

This study tests a group-based program without medication for older adults living in the community who feel their memory is slipping. About 218 people aged 60 and older with mild memory concerns will take part. The program focuses on activities to support memory and thinking, and…